KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $2.89 $5.69 Friday, 26th Apr 2024 CELU stock ended at $3.02. This is 1.63% less than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 16.07% from a day low at $2.89 to a day high of $3.36.
90 days $0.284 $7.97
52 weeks $0.159 $7.97

Historical Celularity Inc. prices

Date Open High Low Close Volume
Apr 26, 2024 $3.08 $3.36 $2.89 $3.02 48 969
Apr 25, 2024 $3.44 $3.74 $3.06 $3.07 239 062
Apr 24, 2024 $3.23 $3.49 $3.21 $3.38 35 983
Apr 23, 2024 $3.04 $3.36 $3.04 $3.21 20 133
Apr 22, 2024 $3.00 $3.27 $3.00 $3.06 26 232
Apr 19, 2024 $3.17 $3.30 $3.03 $3.03 23 459
Apr 18, 2024 $3.29 $3.34 $3.16 $3.21 41 629
Apr 17, 2024 $3.69 $3.69 $3.26 $3.31 35 311
Apr 16, 2024 $4.07 $4.41 $3.44 $3.50 73 901
Apr 15, 2024 $4.30 $4.52 $4.11 $4.20 45 114
Apr 12, 2024 $4.53 $4.74 $4.10 $4.11 70 223
Apr 11, 2024 $4.89 $5.04 $4.57 $4.65 42 035
Apr 10, 2024 $5.40 $5.40 $5.00 $5.05 83 429
Apr 09, 2024 $5.58 $5.64 $5.40 $5.40 15 240
Apr 08, 2024 $5.36 $5.69 $5.32 $5.54 32 673
Apr 05, 2024 $5.02 $5.39 $4.97 $5.32 18 484
Apr 04, 2024 $5.23 $5.25 $4.98 $5.12 28 236
Apr 03, 2024 $4.97 $5.27 $4.89 $5.27 22 288
Apr 02, 2024 $5.09 $5.24 $4.70 $5.00 39 305
Apr 01, 2024 $5.27 $5.30 $5.01 $5.29 74 063
Mar 28, 2024 $5.02 $5.24 $4.90 $5.23 48 212
Mar 27, 2024 $5.07 $5.10 $4.75 $4.94 32 541
Mar 26, 2024 $5.35 $5.35 $4.86 $5.03 66 159
Mar 25, 2024 $5.75 $5.75 $5.00 $5.27 55 004
Mar 22, 2024 $5.31 $5.42 $4.98 $5.19 67 721
Click to get the best stock tips daily for free!

About Celularity Inc.

Celularity. Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-derived CAR-T therapy, which is in Phase I clinical trial for the treatment of B-cell malignancies; CYNK-... CELU Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT